Literature DB >> 1937784

Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.

W N Burnette1, V L Mar, B W Platler, J D Schlotterbeck, M D McGinley, K S Stoney, M F Rohde, H R Kaslow.   

Abstract

Cholera and pertussis toxins each contain a subunit with ADP-ribosyltransferase activity, sharing a region of nearly identical amino acid sequence near the NH2 terminus. Previous investigations have shown that substitution of a lysine residue for Arg-9 in the catalytic A subunit of pertussis toxin substantially eliminates its enzyme activity. We now report that substitution of lysine for the position-equivalent Arg-7 of cholera toxin subunit A leads to a similar loss of catalytic activity. This result suggests a correlation of function with structure between the sequence-related cholera and pertussis toxin A subunits and may contribute to the design of a vaccine containing an enzymatically inert analog of cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937784      PMCID: PMC259028          DOI: 10.1128/iai.59.11.4266-4270.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

3.  Nucleotide sequences within the cholera toxin operon.

Authors:  M L Gennaro; P J Greenaway
Journal:  Nucleic Acids Res       Date:  1983-06-25       Impact factor: 16.971

4.  Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits.

Authors:  N F Pierce; J B Kaper; J J Mekalanos; W C Cray
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition.

Authors:  J J Mekalanos; R J Collier; W R Romig
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

6.  Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.

Authors:  J B Kaper; H Lockman; M M Baldini; M M Levine
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

7.  The expression of biologically active cholera toxin in Escherichia coli.

Authors:  M L Gennaro; P J Greenaway; D A Broadbent
Journal:  Nucleic Acids Res       Date:  1982-08-25       Impact factor: 16.971

8.  Location and amino acid sequence around the ADP-ribosylation site in the cholera toxin active subunit A1.

Authors:  C Y Lai; Q C Xia; P T Salotra
Journal:  Biochem Biophys Res Commun       Date:  1983-10-14       Impact factor: 3.575

9.  Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin.

Authors:  Y Lobet; C W Cluff; W Cieplak
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Evolution and structure of two ADP-ribosylation enterotoxins, Escherichia coli heat-labile toxin and cholera toxin.

Authors:  T Yamamoto; T Nakazawa; T Miyata; A Kaji; T Yokota
Journal:  FEBS Lett       Date:  1984-04-24       Impact factor: 4.124

View more
  13 in total

1.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.

Authors:  M R Fontana; R Manetti; V Giannelli; C Magagnoli; A Marchini; R Olivieri; M Domenighini; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  ModA and ModB, two ADP-ribosyltransferases encoded by bacteriophage T4: catalytic properties and mutation analysis.

Authors:  Bernd Tiemann; Reinhard Depping; Egle Gineikiene; Laura Kaliniene; Rimas Nivinskas; Wolfgang Rüger
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

4.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Authors:  C C Häse; L S Thai; M Boesman-Finkelstein; V L Mar; W N Burnette; H R Kaslow; L A Stevens; J Moss; R A Finkelstein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.

Authors:  Thirumalai R Kannan; Manickam Krishnan; Kumaraguruparan Ramasamy; Argentina Becker; Olga N Pakhomova; P John Hart; Joel B Baseman
Journal:  Mol Microbiol       Date:  2014-07-10       Impact factor: 3.501

Review 6.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

Authors:  B D Spangler
Journal:  Microbiol Rev       Date:  1992-12

7.  Structural inferences for Cholera toxin mutations in Vibrio cholerae.

Authors:  Gunasagaran Shamini; Manickam Ravichandran; John T Sinnott; Charurut Somboonwit; Harcharan S Sidhu; Paul Shapshak; Pandjassarame Kangueane
Journal:  Bioinformation       Date:  2011-03-02

8.  Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.

Authors:  B L Dickinson; J D Clements
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.

Authors:  C C Grant; R J Messer; W Cieplak
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit.

Authors:  M P Matousek; J G Nedrud; W Cieplak; C V Harding
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.